Source: Annual Congress 2006 - New aspects in the pathogenesis of asthma



Rating:

Share or cite this content

Citations should be made in the following way:
S. K. Park, S. K. Kim, C. H. Son, D. K. Yang, S. K. Lee, K. N. Kim, M. S. Roh (Busan, Republic Of Korea). Eosinophilic lung disease: clinical features of 25 patients. Eur Respir J 2006; 28: Suppl. 50, 1397

Member's Comments

No comment yet.

Related content which might interest you: Eosinophilic inflammation in COPD: prevalence and clinical characteristics Source: Eur Respir J 2014; 44: 1697-1700 Year: 2014 Clinical features and outcomes of patients with myositis associated-interstitial lung disease Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021 Clinical characteristics of patients with unclassifiable interstitial lung disease Source: International Congress 2015 – New insights into IIPs Year: 2015 Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features Source: Eur Respir J 2006; 27: 143-150 Year: 2006 Amyloid-and nonamyloid-deposition disease in the lung: novel manifestations Source: Annual Congress 2013 –Ceremony for ERS Award for Rare Pulmonary Disease (financially supported by GlaxoSmithKline) followed by Symposium: Autoimmunity and lung diseases in humans Year: 2013 Severe sarcoidosis: clinical features and management Source: Virtual Congress 2021 – Rare lung diseases 2021 Year: 2021 The characteristics of mycobacterioses in patients with chronic lung diseases Source: International Congress 2019 – Airway infection in COPD Year: 2019 Clinical spectrum of children with interstitial pneumonia with autoimmune features:a new definition in childhood interstitial lung diseases Source: Virtual Congress 2021 – Posters in paediatric bronchology Year: 2021 The clinical characteristics of eosinophilic chronic obstructive pulmonary disease:A cohort study Source: Virtual Congress 2020 – Investigations of COPD Year: 2020 Interstitial lung disease Source: Eur Respir Rev 2013; 22: 26-32 Year: 2013 Nintedanib in patients with chronic fibrosing interstitial lung diseases with progressive phenotype: the INBUILD trial Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Interstitial lung diseases and pulmonary hypertension Year: 2019 The features of sarcoidosis in owerweight patients. Source: Virtual Congress 2021 – Moving forward in various aspects of sarcoidosis Year: 2021 Interstitial lung disease (ILD) in patients with polymyositis/dermatomyositis (PM/DM): clinical features and response to treatment in 6 cases Source: Eur Respir J 2001; 18: Suppl. 33, 528s Year: 2001 Clinical characteristics of 30 patients with interstitial pneumonia associated with anti-aminoacyl-tRNA-synthetase antibodies Source: International Congress 2016 – Connective tissue disorders Year: 2016 Pattern and impact of rheumatology referral in patients with ILD and autoimmune features Source: International Congress 2016 – Connective tissue disorders Year: 2016 Chronic obstructive pulmonary disease (COPD) patients with bronchiectasis: clinical features? Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 Comparison of clinical features between patients of lung cancer with combined pulmonary fibrosis and emphysema syndrome and those with interstitial pneumonia Source: Annual Congress 2012 - Diffuse parenchymal lung disease II Year: 2012 Chronic interstitial lung disease in children: diagnosis and treatment Source: International Congress 2016 – PG6 Lung fibrosis and sarcoidosis Year: 2016 The clinical value of surgical lung biopsy in 166 patients with suspected interstitial lung disease Source: International Congress 2015 – New insights into IIPs Year: 2015